Retatrutide
MetabolicRetatrutide (LY3437943) is a triple agonist of the GIP, GLP-1 and glucagon receptors, studied in research contexts for incretin-pathway and metabolic regulation.
- Class
- Metabolic
- Also known as
- Retatrutide (LY3437943)
- Molar mass
- 4731.4 g/mol
- Common research uses
- LY3437943, GLP-1, GIP
- Human half-life
- Not well characterised — in humans
- Regulatory status
- Research use only — not approved for human use
What Retatrutide is and how it works
Retatrutide is a triple GIP, GLP-1 and glucagon receptor agonist studied in research contexts for incretin-pathway and metabolic regulation.
Researched effects
We are writing and source-checking this section before it goes live. We would rather leave it blank than publish unverified information.
Side effects and safety considerations
We are writing and source-checking this section before it goes live. We would rather leave it blank than publish unverified information.
Reconstitution & dosing
Dosing protocols in the literature are for research models only. Use the calculator below to work out reconstitution volumes.
Optional — used to check the volume fits.
This is a reconstitution math tool for research purposes only. It is not medical advice and does not constitute a dosing recommendation.
Where to find Retatrutide
Peptide Scanner is an independent research aggregator. We list retailer prices and link out — retailers remain the source of truth for stock and pricing.
As of today, Retatrutide is compared across 14 suppliers — lowest tracked price $2.50/mg.
Compare Retatrutide pricesFrequently asked questions
We are writing and source-checking this section before it goes live. We would rather leave it blank than publish unverified information.
Related peptides
Peptide Scanner is an independent, affiliate-funded information service. We do not sell, fulfil, or endorse any product. Information on this page is reference material for research use only and is not medical advice.